REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Commermega Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Commermega Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Commermega Sdn. Bhd operates in the healthcare industry. The company sells medical and surgical products, medical instruments and accessories, laboratory equipment and accessories, and medical disposable items. Its target market includes government and private hospitals in Malaysia. The number of employees and revenue are not available.

Headquarters
No 12A, Jalan Impian Makmur 3/A, Taman Saujana Impian
Kajang; Selangor; Postal Code: 43000

Contact Details: Purchase the Commermega Sdn. Bhd. report to view the information.

Website: http://www.commermega.net

Basic Information
Total Employees:
Purchase the Commermega Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Commermega Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Commermega Sdn. Bhd. report to view the information.
Incorporation Date:
November 10, 1997
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Commermega Marketing Sdn. Bhd.
60%
Company Performance
Financial values in the chart are available after Commermega Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
49.43%▲
Total operating revenue
49.43%▲
Operating Profit/Loss (EBIT)
114.66%▲
EBITDA
18.43%▲
Net Profit/Loss for the Period
196.44%▲
Total Assets
98.09%▲
Total Equity
70.64%▲
Operating Profit Margin (ROS)
0.28%▲
Net Profit Margin
0.34%▲
Return on Equity (ROE)
3.28%▲
Debt/Equity
-83.8%▼
Quick Ratio
-0.22%▼
Cash Ratio
0.36%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo